US Stock MarketDetailed Quotes

XFORW X4 PHARMACEUTICALS INC C/WTS 16/04/24(TO PUR COM) CL A

Watchlist
  • 0.001
  • 0.0000.00%
15min DelayClose Apr 9 16:00 ET
0Market Cap0.00P/E (TTM)

X4 PHARMACEUTICALS INC C/WTS 16/04/24(TO PUR COM) CL A Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
22.08%107.52M
-1.48%25.2M
35.03%27.21M
25.45%25.81M
34.56%29.3M
16.89%88.08M
32.54%25.58M
5.41%20.15M
8.28%20.57M
21.42%21.78M
Selling and administrative expenses
31.40%35.51M
51.26%9.93M
34.56%8.13M
51.19%10.2M
-5.52%7.24M
9.38%27.02M
-8.02%6.56M
1.91%6.04M
16.28%6.75M
31.41%7.66M
Research and development costs
17.95%72.02M
-19.68%15.27M
35.23%19.08M
12.88%15.6M
56.33%22.06M
20.56%61.06M
56.34%19.01M
6.99%14.11M
4.76%13.82M
16.60%14.11M
Operating profit
-22.08%-107.52M
1.48%-25.2M
-35.03%-27.21M
-25.45%-25.81M
-34.56%-29.3M
-16.89%-88.08M
-32.54%-25.58M
-5.41%-20.15M
-8.28%-20.57M
-21.42%-21.78M
Net non-operating interest income expense
68.34%-1.2M
53.38%-441K
75.50%-246K
74.40%-234K
69.89%-274K
-3.91%-3.77M
-2.60%-946K
-9.37%-1M
-1.33%-914K
-2.36%-910K
Non-operating interest income
1,992.24%4.58M
629.80%1.45M
9,814.29%1.39M
22,750.00%914K
27,733.33%835K
2,090.00%219K
6,500.00%198K
600.00%14K
33.33%4K
50.00%3K
Non-operating interest expense
44.68%5.78M
64.86%1.89M
60.51%1.63M
25.05%1.15M
21.47%1.11M
9.64%3.99M
23.68%1.14M
10.65%1.02M
1.44%918K
2.47%913K
Other net income (expense)
483.90%7.63M
354.89%6.54M
5,809.98%25.18M
-10,845.65%-29.66M
646.58%5.56M
79.51%-1.99M
74.29%-2.57M
-224.26%-441K
3.37%276K
380.65%745K
Gain on sale of security
315.87%7.07M
432.02%6.33M
--25.16M
-9,013.43%-29.86M
2,990.34%5.44M
564.75%1.7M
460.61%1.19M
----
487.72%335K
667.74%176K
Special income (charges)
--0
--0
--0
--0
--0
105.22%509K
--0
--0
--0
--509K
-Less:Impairment of capital assets
--0
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
--0
--0
--0
--0
--0
--509K
--0
--0
--0
--509K
Other non- operating income (expenses)
113.20%554K
105.64%212K
103.85%17K
442.37%202K
105.00%123K
-1,085.21%-4.2M
-3,747.57%-3.76M
-495.95%-441K
-128.10%-59K
-67.74%60K
Income before tax
-7.73%-101.09M
34.35%-19.1M
89.45%-2.28M
-162.62%-55.7M
-9.45%-24.02M
-5.82%-93.84M
3.69%-29.09M
-7.07%-21.6M
-8.03%-21.21M
-17.53%-21.94M
Income tax
178.57%78K
135.71%33K
300.00%26K
275.00%15K
-82.61%4K
64.71%28K
366.67%14K
-750.00%-13K
-33.33%4K
283.33%23K
Net income
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
-6.99%-21.59M
-8.02%-21.21M
-17.61%-21.97M
Net income continuous Operations
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
-6.99%-21.59M
-8.02%-21.21M
-17.61%-21.97M
Minority interest income
Net income attributable to the parent company
-7.78%-101.17M
34.27%-19.13M
89.32%-2.31M
-162.64%-55.71M
-9.36%-24.02M
-5.83%-93.87M
3.65%-29.1M
-6.99%-21.59M
-8.02%-21.21M
-17.61%-21.97M
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
-81.74%2.55M
0
287K
0
-72.58%2.26M
Net income attributable to common stockholders
-4.93%-101.17M
34.27%-19.13M
89.46%-2.31M
-162.64%-55.71M
0.84%-24.02M
6.07%-96.41M
18.96%-29.1M
-8.42%-21.87M
-8.02%-21.21M
10.00%-24.22M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 22.08%107.52M-1.48%25.2M35.03%27.21M25.45%25.81M34.56%29.3M16.89%88.08M32.54%25.58M5.41%20.15M8.28%20.57M21.42%21.78M
Selling and administrative expenses 31.40%35.51M51.26%9.93M34.56%8.13M51.19%10.2M-5.52%7.24M9.38%27.02M-8.02%6.56M1.91%6.04M16.28%6.75M31.41%7.66M
Research and development costs 17.95%72.02M-19.68%15.27M35.23%19.08M12.88%15.6M56.33%22.06M20.56%61.06M56.34%19.01M6.99%14.11M4.76%13.82M16.60%14.11M
Operating profit -22.08%-107.52M1.48%-25.2M-35.03%-27.21M-25.45%-25.81M-34.56%-29.3M-16.89%-88.08M-32.54%-25.58M-5.41%-20.15M-8.28%-20.57M-21.42%-21.78M
Net non-operating interest income expense 68.34%-1.2M53.38%-441K75.50%-246K74.40%-234K69.89%-274K-3.91%-3.77M-2.60%-946K-9.37%-1M-1.33%-914K-2.36%-910K
Non-operating interest income 1,992.24%4.58M629.80%1.45M9,814.29%1.39M22,750.00%914K27,733.33%835K2,090.00%219K6,500.00%198K600.00%14K33.33%4K50.00%3K
Non-operating interest expense 44.68%5.78M64.86%1.89M60.51%1.63M25.05%1.15M21.47%1.11M9.64%3.99M23.68%1.14M10.65%1.02M1.44%918K2.47%913K
Other net income (expense) 483.90%7.63M354.89%6.54M5,809.98%25.18M-10,845.65%-29.66M646.58%5.56M79.51%-1.99M74.29%-2.57M-224.26%-441K3.37%276K380.65%745K
Gain on sale of security 315.87%7.07M432.02%6.33M--25.16M-9,013.43%-29.86M2,990.34%5.44M564.75%1.7M460.61%1.19M----487.72%335K667.74%176K
Special income (charges) --0--0--0--0--0105.22%509K--0--0--0--509K
-Less:Impairment of capital assets --0------------------0----------------
-Gain on sale of property,plant,equipment --0--0--0--0--0--509K--0--0--0--509K
Other non- operating income (expenses) 113.20%554K105.64%212K103.85%17K442.37%202K105.00%123K-1,085.21%-4.2M-3,747.57%-3.76M-495.95%-441K-128.10%-59K-67.74%60K
Income before tax -7.73%-101.09M34.35%-19.1M89.45%-2.28M-162.62%-55.7M-9.45%-24.02M-5.82%-93.84M3.69%-29.09M-7.07%-21.6M-8.03%-21.21M-17.53%-21.94M
Income tax 178.57%78K135.71%33K300.00%26K275.00%15K-82.61%4K64.71%28K366.67%14K-750.00%-13K-33.33%4K283.33%23K
Net income -7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M-6.99%-21.59M-8.02%-21.21M-17.61%-21.97M
Net income continuous Operations -7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M-6.99%-21.59M-8.02%-21.21M-17.61%-21.97M
Minority interest income
Net income attributable to the parent company -7.78%-101.17M34.27%-19.13M89.32%-2.31M-162.64%-55.71M-9.36%-24.02M-5.83%-93.87M3.65%-29.1M-6.99%-21.59M-8.02%-21.21M-17.61%-21.97M
Preferred stock dividends
Other preferred stock dividends 00000-81.74%2.55M0287K0-72.58%2.26M
Net income attributable to common stockholders -4.93%-101.17M34.27%-19.13M89.46%-2.31M-162.64%-55.71M0.84%-24.02M6.07%-96.41M18.96%-29.1M-8.42%-21.87M-8.02%-21.21M10.00%-24.22M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg